About Antares Medicines For Partners For Investors For PatientsCareers Contact Us SEC Filings Search By Keyword: Filter By Year: - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 Filter By Type: All Fillings 10-K 10-K/A 10-K405 10-K405/A 10-Q 10-Q/A 25 424A 424B1 424B2 424B3 424B5 425 8-A12B 8-A12G 8-K 8-K/A ARS CERTAMX CORRESP CT ORDER DEF 14A DEFA14A DEFM14A DEFR14A EFFECT FWP NT 10-K NT 10-Q POS AM PRE 14A PREM14A PRER14A REGDEX REGDEX/A S-1 S-1/A S-2 S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A UPLOAD Next Showing 1 to 50 of 550 Date Title Type 2021-11-04 8-K - Current report 8-K 2021-11-04 10-Q - Quarterly report [Sections 13 or 15(d)] 10-Q 2021-11-02 8-K - Current report 8-K 2021-10-28 8-K - Current report 8-K 2021-10-18 8-K - Current report 8-K 2021-08-18 8-K - Current report 8-K 2021-08-05 10-Q - Quarterly report [Sections 13 or 15(d)] 10-Q 2021-08-05 8-K - Current report 8-K 2021-06-24 S-8 - Securities to be offered to employees in em S-8 2021-06-15 8-K - Current report 8-K 2021-06-01 8-K - Current report 8-K 2021-05-06 8-K - Current report 8-K 2021-05-06 10-Q - Quarterly report [Sections 13 or 15(d)] 10-Q 2021-04-27 DEFA14A - Additional definitive proxy soliciting DEFA14A 2021-04-27 DEF 14A - Other definitive proxy statements DEF 14A 2021-03-05 8-K - Current report 8-K 2021-03-02 10-K - Annual report [Section 13 and 15(d), not S 10-K 2021-03-02 8-K - Current report 8-K 2021-01-28 SC 13G/A [Amend] - Statement of acquisition of be SC 13G/A 2021-01-11 8-K - Current report 8-K 2020-11-12 8-K - Current report 8-K 2020-11-05 10-Q - Quarterly report [Sections 13 or 15(d)] 10-Q 2020-11-05 8-K - Current report 8-K 2020-10-01 8-K - Current report 8-K 2020-09-21 8-K - Current report 8-K 2020-08-06 8-K - Current report 8-K 2020-08-06 10-Q - Quarterly report [Sections 13 or 15(d)] 10-Q 2020-06-16 8-K - Current report 8-K 2020-05-05 8-K - Current report 8-K 2020-05-05 10-Q - Quarterly report [Sections 13 or 15(d)] 10-Q 2020-04-27 DEF 14A - Other definitive proxy statements DEF 14A 2020-04-27 DEFA14A - Additional definitive proxy soliciting DEFA14A 2020-04-09 8-K - Current report 8-K 2020-03-04 8-K - Current report 8-K 2020-03-03 8-K - Current report 8-K 2020-03-03 10-K - Annual report [Section 13 and 15(d), not S 10-K 2020-02-14 SC 13G/A [Amend] - Statement of acquisition of be SC 13G/A 2020-02-11 SC 13G/A [Amend] - Statement of acquisition of be SC 13G/A 2020-02-05 SC 13G/A [Amend] - Statement of acquisition of be SC 13G/A 2020-01-27 8-K - Current report 8-K 2020-01-13 8-K - Current report 8-K 2019-11-05 10-Q - Quarterly report [Sections 13 or 15(d)] 10-Q 2019-11-05 8-K - Current report 8-K 2019-09-10 8-K - Current report 8-K 2019-08-06 10-Q - Quarterly report [Sections 13 or 15(d)] 10-Q 2019-08-06 8-K - Current report 8-K 2019-07-23 S-8 - Securities to be offered to employees in em S-8 2019-07-05 8-K - Current report 8-K 2019-06-27 8-K - Current report 8-K 2019-06-18 8-K - Current report 8-K Next Showing 1 to 50 of 550 For Investors Press SEC Filings Webcasts & Presentations Analyst Coverage Corporate Governance and Committee Charters Interactive Data Filings (XBRL) Q3 2018 10-Q XBRL.zip Q2 2018 10-Q XBRL.zip Q1 2018 10-Q XBRL.zip 2017 10-K xbrl.zip Q3 2017 10-Q XBRL.zip Q2 2017 10-Q XBRL.zip Q1 2017 10-Q XBRL.zip This site ©2021 Antares Pharma. All Rights Reserved About Antares Medicines For Partners For Investors For Patients Careers Contact Us Privacy Policy